64

Acute kidney injury prevention new microsoft power po.int presentation

Embed Size (px)

Citation preview

Page 1: Acute kidney injury prevention new microsoft power po.int presentation
Page 2: Acute kidney injury prevention new microsoft power po.int presentation

objectives Definition of acute kidney injury

Diagnosis , prevalence , aetiology , RIFLE crietria , AKI crieteria ,………. Already discussed

Page 3: Acute kidney injury prevention new microsoft power po.int presentation
Page 4: Acute kidney injury prevention new microsoft power po.int presentation
Page 5: Acute kidney injury prevention new microsoft power po.int presentation
Page 6: Acute kidney injury prevention new microsoft power po.int presentation

Clinical Approach to AKI:

Pre-, Intra-, and Post-Renal

History Volume status

Ultrasound Urinalysis US shows

Hydronephrosis

Post-Renal

Urinalysis Normal

Urinalysis Abnormal

Tubulointerstial Disorders

Glomerular and Vascular Disorders

Pre-renal

Page 7: Acute kidney injury prevention new microsoft power po.int presentation

Urinalysis in Acute Kidney Injury

Prerenal Postrenal Oncotic AKI

Glomerulopathy Vasculitis

Thrombotic MA

Pyelonephritis Interstitial nephritis

AIN Athero- embolic

AKI

ATN Myoglobin Hemoglobin

Uric acid Toxins Drugs

Plasma cell dyscrasia

Hematuria RBC casts proteinuria

WBC WBC casts

Eosinophils RTE cells Pigmented

casts

Crystalluria Non- albumin

proteinuria

Abnormal sediment Normal/bland

Page 8: Acute kidney injury prevention new microsoft power po.int presentation

Schrier, Diseases of the Kidney

Page 9: Acute kidney injury prevention new microsoft power po.int presentation

Pathophysiology of Ischemic and Toxic Acute

Renal Failure

MICROVASCULAR TUBULAR

Vasoconstriction

endothelin, adenosine,

angiotensin II, thromboxane A2,

leukotrienes, sympathetic nerve

activity

Vasodilation

nitric oxide, PGE2, acetylcholine

bradykinin

Cytoskeletal

breakdown

Loss of polarity

Apoptosis and

Necrosis

Desquamation of

viable and necrotic

cells

Tubular obstruction

Backleak

Glomerular Medullary

O2/TOXINS

Inflammatory

and

vasoactive

mediators

Endothelial and vascular smooth

muscle cell structural damage

Leukocyte-Endothelial adhesion

vascular obstruction, leukocyte

activation, and inflammation

Page 10: Acute kidney injury prevention new microsoft power po.int presentation

Schrier, Diseases of the Kidney

Page 11: Acute kidney injury prevention new microsoft power po.int presentation
Page 12: Acute kidney injury prevention new microsoft power po.int presentation
Page 13: Acute kidney injury prevention new microsoft power po.int presentation
Page 14: Acute kidney injury prevention new microsoft power po.int presentation
Page 15: Acute kidney injury prevention new microsoft power po.int presentation
Page 16: Acute kidney injury prevention new microsoft power po.int presentation
Page 17: Acute kidney injury prevention new microsoft power po.int presentation
Page 18: Acute kidney injury prevention new microsoft power po.int presentation
Page 19: Acute kidney injury prevention new microsoft power po.int presentation
Page 20: Acute kidney injury prevention new microsoft power po.int presentation
Page 21: Acute kidney injury prevention new microsoft power po.int presentation
Page 22: Acute kidney injury prevention new microsoft power po.int presentation
Page 23: Acute kidney injury prevention new microsoft power po.int presentation
Page 24: Acute kidney injury prevention new microsoft power po.int presentation
Page 25: Acute kidney injury prevention new microsoft power po.int presentation
Page 26: Acute kidney injury prevention new microsoft power po.int presentation
Page 27: Acute kidney injury prevention new microsoft power po.int presentation
Page 28: Acute kidney injury prevention new microsoft power po.int presentation
Page 29: Acute kidney injury prevention new microsoft power po.int presentation

However ……..

Page 30: Acute kidney injury prevention new microsoft power po.int presentation
Page 31: Acute kidney injury prevention new microsoft power po.int presentation
Page 32: Acute kidney injury prevention new microsoft power po.int presentation
Page 33: Acute kidney injury prevention new microsoft power po.int presentation
Page 34: Acute kidney injury prevention new microsoft power po.int presentation
Page 35: Acute kidney injury prevention new microsoft power po.int presentation
Page 36: Acute kidney injury prevention new microsoft power po.int presentation

What about MRI….. US IT SAFE

Page 37: Acute kidney injury prevention new microsoft power po.int presentation
Page 38: Acute kidney injury prevention new microsoft power po.int presentation
Page 39: Acute kidney injury prevention new microsoft power po.int presentation
Page 40: Acute kidney injury prevention new microsoft power po.int presentation
Page 41: Acute kidney injury prevention new microsoft power po.int presentation
Page 42: Acute kidney injury prevention new microsoft power po.int presentation
Page 43: Acute kidney injury prevention new microsoft power po.int presentation

AKI: Rhabdomyolysis Precipitated by trauma/crush injury, extreme exertion,

statins, cocaine, envenomation, hypoK, hypoPO4

Multifold injury, with volume depletion, direct tubular toxicity, and obstructing pigment casts

UA: granular casts, (+) bld on dipstick but (-) microscopy

due to myoglobin pigment

CK levels not always consistent in predicting AKI, but general consensus is that low likelihood exists with CK levels less than 5k-10k

Page 44: Acute kidney injury prevention new microsoft power po.int presentation

Rhabdomyolysis

Endotoxin cascade

Activation of ET NO

scavenging

Muscular vasodilatation and uptake of

ECF in damaged muscles

Increased load of PO4 and urate

Myoglobinemia Hyperuricemia

Hypovolemia, CV suppression due

to hi K, lo Ca, Met Acidosis

Myoglobinuria Uricosuria

Renal vasoconstriction, ischemia

Pigment nephrotoxicity

Tubular cast formation and stasis

Depletion of ATP stores,

synergistic tubular damage

ATN

Zager RA, Kidney Int 1996; 49: 314-326

Page 45: Acute kidney injury prevention new microsoft power po.int presentation

AKI: Rhabdomyolysis Treatment is via forced saline diuresis: goal of UOP >

200-300 mL/hr

Early hydration: in crush victims, IV begun in field, advised even before full extrication (Turkey earthquake, 1999)

Urinary alkanization

Treatment for symptomatic hypocalcemia only: watch for hyperK

Page 46: Acute kidney injury prevention new microsoft power po.int presentation
Page 47: Acute kidney injury prevention new microsoft power po.int presentation

Atheroembolic (AE) AKI

Renal and systemic AE occur in patients with diffuse atheroscerotic disease

Risk factors include manipulation of the aorta or other large arteries during angiography or CV surgery

Also can occur spontaneously with ulcerated plaques

Destabilization of plaque may be enhanced in the setting

of anticoagulation or thrombolytic therapy

Page 48: Acute kidney injury prevention new microsoft power po.int presentation

Atheroembolic AKI

Clinical Manifestations

AKI days to weeks after manipulation, anticoagulation

Systemic signs, signals of inflammation

Rash

Livedo reticularis

Decreased complement due to activation by exposed atheromata

Eosinophilia/eosinophiliuria

Occlusion of distal arteriolar beds

AKI

Visual field deficits

Gangrenous digits, palpable pulses

Pancreatitis

GI bleeding

Page 49: Acute kidney injury prevention new microsoft power po.int presentation
Page 50: Acute kidney injury prevention new microsoft power po.int presentation

Acute Kidney Injury

Clinical features of Acute Interstitial Nephritis Onset usually 3-5 days with most drugs, but may be sooner with

rifampin, or much later with NSAIDS

Rising SCr which resolves upon d/c of offending drug

Fever, hematuria, pyuria: Urine eosinophils

Mild to moderate proteinuria; much higher to NS in NSAIDS

Eosinophilia and morbilliform rash also s/sx in AIN

Occasionally see hyperkalemia and distal RTA

Prednisone 40 mg PO x 2 wks sometimes utilized to shorten AKI interval

Page 51: Acute kidney injury prevention new microsoft power po.int presentation

Schrier, Diseases of the Kidney

Page 52: Acute kidney injury prevention new microsoft power po.int presentation

Schrier, Diseases of the Kidney

Page 53: Acute kidney injury prevention new microsoft power po.int presentation

Acute Kidney Injury: AIN causes

DRUGS ACEI

Allopurinol

Cephalosporins

Cimetidine

Fluoroquinolones

Loop diuetics

NSAIDS

Phenytoin

Rifampin

Sulfonamides

Tegretol

Thiazides

INFECTION Bacterial

Agents causing pyelonephritis

Legionella

Brucella

Yersinia

Viral

Hantavirus

HIV

CMV,EBV,HSV

Page 54: Acute kidney injury prevention new microsoft power po.int presentation
Page 55: Acute kidney injury prevention new microsoft power po.int presentation

Acute Kidney injury Crystal-induced AKI:

Common factors include high excretion in urine, and low solubility in acidic urine; exacerbated by hypovolemia; examination of urine critical to Dx

Common agents Uric acid

Acyclovir

Sulfa

Methotrexate

Ethylene glycol

Pre-exposure hydration, Urinary alkalinization

Page 56: Acute kidney injury prevention new microsoft power po.int presentation
Page 57: Acute kidney injury prevention new microsoft power po.int presentation

Hemolytic Uremic Syndrome

One of the most common causes of community-acquired

AKI in young children

Triad of microangiopathic hemolytic anemia,

thrombocytopenia, and renal insufficiency

HUS has clinical features in common with thrombotic

thrombocytopenic purpura (TTP) which is also characterized

by these features but can include central nervous system

(CNS) involvement and fever and can have a more gradual

onset

A low platelet count can usually, but not always, be detected

early in the illness, but it can then become normal or even

high. If a platelet count obtained within 7 days after onset of

the acute gastrointestinal illness is not <150,000/mm3, other

diagnoses should be considered

Page 58: Acute kidney injury prevention new microsoft power po.int presentation

Terminology and Classification

Page 59: Acute kidney injury prevention new microsoft power po.int presentation

Microangiophathic hemolytic anemia with fragmented erythrocytes (schistocytes)

Page 60: Acute kidney injury prevention new microsoft power po.int presentation

Acute Kidney Injury

Indications for Renal Biopsy in AKI:

Acute nephritic syndrome

Hematuria, cellular casts, proteinuria in setting of new-onset or exacerbation of HTN, rising SCr

May also have serologic (+) i.e. ANA, ANCA, aGBM that tissue dx also provides treatment options and prognosis

Unexplained AKI

Uncertain or multiple competing ddx, of which treatment differs greatly with definitive dx; AIN vs ATN considerations are seen not uncommonly in hospitalized pts

Young pts with AKI often are considered based on long-term renal survival outcomes maximized with definitive dx

Renal TPL: Acute Rejection

Page 61: Acute kidney injury prevention new microsoft power po.int presentation
Page 63: Acute kidney injury prevention new microsoft power po.int presentation

Classic Indications for RRT

A—acidosis

E—electrolyte disturbances

I—intoxication

O—overload

U—uremia

Page 64: Acute kidney injury prevention new microsoft power po.int presentation